Evidence map›Paper›PMID 32490754›Full record

ArticleVirulence2020

Clinical and epidemiological characterization of severe

Anupkumar R Anvikar, Anna Maria van Eijk, Asha Shah, Kamlesh J Upadhyay, Steven A Sullivan, Ankita J Patel, Jaykumar M Joshi, Suchi Tyagi, Ranvir Singh, Jane M Carlton and 2 more

Abstract read
In one paragraph

Article in Virulence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Rapid Detection ofDiagnostics (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Diagnosis of cerebral malaria: Tools to reduceFrontiers in cellular and infection microbiology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Harnessing the Potential of miRNAs in Malaria Diagnostic and Prevention.Frontiers in cellular and infection microbiology · 2021
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anupkumar R AnvikarIndian Council of Medical Research (ICMR), National Institute of Malaria Research , New Delhi, India.
Anna Maria van EijkCenter for Genomics and Systems Biology, Department of Biology, New York University , New York, NY, USA.
Asha ShahByramjee Jeejeebhoy Medical College (BJMC), Civil Hospital , Ahmedabad, India.
Kamlesh J UpadhyayByramjee Jeejeebhoy Medical College (BJMC), Civil Hospital , Ahmedabad, India.
Steven A SullivanCenter for Genomics and Systems Biology, Department of Biology, New York University , New York, NY, USA.
Ankita J PatelByramjee Jeejeebhoy Medical College (BJMC), Civil Hospital , Ahmedabad, India.
Jaykumar M JoshiByramjee Jeejeebhoy Medical College (BJMC), Civil Hospital , Ahmedabad, India.
Suchi TyagiByramjee Jeejeebhoy Medical College (BJMC), Civil Hospital , Ahmedabad, India.
Ranvir SinghByramjee Jeejeebhoy Medical College (BJMC), Civil Hospital , Ahmedabad, India.
Jane M CarltonCenter for Genomics and Systems Biology, Department of Biology, New York University , New York, NY, USA.
Himanshu GuptaDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine , London, UK.
Samuel C WassmerDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine , London, UK.ORCID 0000-0002-6753-3376

Funding

Using Next-Generation Genomics to Study Antimalarial Drug Resistance in IndiaU19AI089676 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARLTON, JANE M · 2010 to 2023
$22.6M
Medical Research Council MR/S009450/1NIAID NIH HHS U19 AI089676
6 · The paper itself

Abstract

The mounting evidence supporting the capacity of

Indexed as

Severity of Illness IndexAdolescentAdultAntimalarialsChildChild, PreschoolFemaleHumansIndiaMalaria, VivaxMaleMiddle AgedPlasmodium vivaxProspective StudiesYoung AdultAntimalarialsGujaratIndiamalaria eliminationPlasmodium vivaxSevere malaria

Identifiers

PMID32490754
PMCPMC7549892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.